Register  /  Login               
P. 41-46 /

China: the emerging market for clinical research

ANDREW C. CHANG
PharmaNet Development Group, Inc.
504 Carnegie Center
Princeton, NJ 08540, USA

Abstract

The improved regulatory andeconomic environment,combined with rapid patient recruitment and a largepopulation’s growing need for healthcare treatment make acountry like China very attractive market for conductingclinical trials. Data on www.clinicaltrials.gov, one of the mostcomprehensive websites where researches register theirstudies, show that China has a cumulative total of 1725completed or ongoing trials by April 2010. With a robust clinicalresearch infrastructure and improved regulatory framework,China is a leading contributor to the annual growth rate ofclinical trials (1).


...



About us



tks | publisher, event organiser,
media agency

Viale Brianza, 22
20127 - Milano - Italy

info@teknoscienze.com
Tel. +39 02 26809375